Patents by Inventor Jose L. Walewski

Jose L. Walewski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alternate reading frame hepatitis C virus peptides and uses thereof
    Patent number: 7785598
    Abstract: Novel hepatitis C virus (HCV) polypeptides are provided which are not encoded by the standard HCV open reading frame. These alternate reading frame polypeptides are useful, inter alia, in vaccine compositions, in diagnosing HCV infection, and as therapeutic targets.
    Type: Grant
    Filed: February 20, 2007
    Date of Patent: August 31, 2010
    Inventors: Andrea D. Branch, Jose L. Walewski, Decherd D. Stump
  • ALTERNATE READING FRAME POLYPEPTIDES DERIVED FROM HEPATITIS C AND METHODS OF THEIR USE
    Publication number: 20100152110
    Abstract: Novel hepatitis C virus (HCV) polypeptides are provided which are not encoded by the standard HCV open reading frame. These alternate reading frame polypeptides are useful, inter alia, in vaccine compositions, in diagnosing HCV infection, and as therapeutic targets.
    Type: Application
    Filed: August 14, 2009
    Publication date: June 17, 2010
    Applicant: MOUNT SINAI MEDICAL CENTER
    Inventors: Andrea D. BRANCH, Jose L. WALEWSKI, Decherd D. STUMP
  • Hepatitis C virus peptides and uses thereof
    Patent number: 7198891
    Abstract: Novel hepatitis C virus (HCV) polypeptides are provided which are not encoded by the standard HCV open reading frame. These alternate reading frame polypeptides are useful, inter alia, in vaccine compositions, in diagnosing HCV infection, and as therapeutic targets.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: April 3, 2007
    Inventors: Andrea D. Branch, Jose L. Walewski, Decherd D. Stump
  • Hepatitis C virus peptides and uses thereof
    Patent number: 7052830
    Abstract: Novel hepatitis C virus (HCV) polypetides are provided which are not encoded by the standard HCV open reading frame. These alternate reading frame polypeptides are useful, inter alia, in vaccine compositions, in diagnosing HCV infection, and as therapeutic targets.
    Type: Grant
    Filed: June 9, 1999
    Date of Patent: May 30, 2006
    Inventors: Andrea D. Branch, Jose L. Walewski, Decherd D. Stump
  • Novel hepatitis C virus peptides and uses thereof
    Publication number: 20040156862
    Abstract: Novel hepatitis C virus (HCV) polypeptides are provided which are not encoded by the standard HCV open reading frame. These alternate reading frame polypeptides are useful, inter alia, in vaccine compositions, in diagnosing HCV infection, and as therapeutic targets.
    Type: Application
    Filed: June 20, 2003
    Publication date: August 12, 2004
    Inventors: Andrea D. Branch, Jose L. Walewski, Decherd D. Stump
  • CDNA fragments corresponding to voltage gated sodium channel genes expressed in peripheral nerve
    Patent number: 6060271
    Abstract: The present invention is directed to isolated nucleic acid molecules encoding a voltage gated sodium channel of a peripheral nerve cell, as well as to the isolated voltage gated sodium channels of a peripheral nerve cell encoded thereby. Methods for increasing or decreasing the expression of functional voltage gated sodium channels in host cells are also provided, as well as methods using the sodium channels. Also provided is a method for isolating other voltage gated sodium channels.
    Type: Grant
    Filed: February 9, 1996
    Date of Patent: May 9, 2000
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Jose L. Walewski, Esperanza Recio-Pinto